RUA Life Sciences (FRA:AOHA) Accounts Payable & Accrued Expense : €0.22 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is RUA Life Sciences Accounts Payable & Accrued Expense?

RUA Life Sciences's quarterly accounts payable & accrued expense increased from Mar. 2023 (€0.06 Mil) to Sep. 2023 (€0.24 Mil) but then declined from Sep. 2023 (€0.24 Mil) to Mar. 2024 (€0.22 Mil).

RUA Life Sciences's annual accounts payable & accrued expense declined from Mar. 2022 (€0.31 Mil) to Mar. 2023 (€0.06 Mil) but then increased from Mar. 2023 (€0.06 Mil) to Mar. 2024 (€0.22 Mil).

RUA Life Sciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for RUA Life Sciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences Accounts Payable & Accrued Expense Chart

RUA Life Sciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.13

0.85

0.31

0.06

0.22

RUA Life Sciences Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.31	0.45	0.06	0.24	0.22

RUA Life Sciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

RUA Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (FRA:AOHA) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

RUA:UK

Address

2 Drummond Crescent, Ayrshire, Scotland, Irvine, GBR, KA11 5AN

Website

https://www.rualifesciences.com

RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.

RUA Life Sciences Headlines

No Headlines